Shares of Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $52.25 and last traded at $52.25, with a volume of 0 shares traded. The stock had previously closed at $52.25.
Recordati Industria Chimica e Farmaceutica Price Performance
The company has a market cap of $10.78 billion, a price-to-earnings ratio of 18.86 and a beta of 0.33. The company has a current ratio of 1.36, a quick ratio of 0.95 and a debt-to-equity ratio of 0.73. The company has a fifty day moving average price of $51.69 and a two-hundred day moving average price of $51.63.
Recordati Industria Chimica e Farmaceutica Company Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Read More
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- How to Calculate Inflation Rate
- Buy On Holdings Stock Before the Market Catches Its Second Wind?
- Why Invest in High-Yield Dividend Stocks?
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
